Extension of approval periods for Flutolanil and Fenpyroximate

The approval periods of the active substances Flutolanil and Fenpyroximate have been extended for 1 year (to 29 February and 30 April 2020, respectively), until a decision on their renewal of the approval has been taken. Please check Commission Implementing Regulation (EU) 2019/168 of 31 January 2019.